20515 results for «»

Filter By

20515 results

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

Amulet IDE: Amplatzer Amulet Left Atrial Appendage Occluder RCT - 12-Month Closure Follow-up

04 Nov 2021

Ali Nazmi Calik reviews Amulet IDE, a prospective, randomized, multi-center and active-control trial designed to compare the Amulet and Watchman 2.5 devices in a head-to-head fashion, and presented by Dhanunjaya Lakkireddy during TCT 2021.

Author

Ali Nazmi Calik
AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

04 Nov 2021

The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.

Francesco Costa

Author

Francesco Costa
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure

GUIDE-HF: can continuous pulmonary artery pressure monitoring improve heart failure management?

09 Nov 2021

The main goal of the randomized GUIDE-HF trial was to assess the ability of continuous PAP monitoring to improve outcomes in patients with heart failure NYHA class II-IV and a HF hospitalization within previous 12 months or elevated BNP/NT-proBNP. 

Dejan Milasinovic

Author

Dejan Milasinovic
GUIDE-HF: can continuous pulmonary artery pressure monitoring improve heart failure management?

Alexandra Castelo

Lisbon, Portugal

Soohyun Alice Chang

Plano, United States of America

Andrew Chatfield

Wellington, Canada

Gideon N. Cohen

Toronto, Canada

David Aritza Conty Cardona

Pamplona, Spain

Victoria Cook

NSW, Australia

Complications: calcified LM-LAD PCI, CHIP and TAVI

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them. 

Complications: calcified

Oliver Deutsch

Munich, Germany

Francesca Maria Di Muro

Salerno, Italy

Elena Dipietro

Metropolitan city of Catania, Italy

Ahmed Elkoumy

Cairo, Ireland

Sarah Fellows

Swindon, United Kingdom

Carlos Fernandez

Katowice, Poland

Jérôme Ferrara

MARSEILLE, France

Vera Ferreira

Lisbon, Portugal

Didn’t find what you were looking for?